on-site brochure
Transcription
on-site brochure
the MICHIGAN SOCIETY of THORACIC & CARDIOVASCULAR SURGEONS 51st ANNUAL SUMMER MEETING ON-SITE BROCHURE BOYNE MOUNTAIN RESORT BOYNE FALLS, MICHIGAN AUGUST 11TH -14TH, 2016 PHONE: 517.252.4234 OR EMAIL: [email protected] OR VISIT WWW.MSTCVS.ORG mscvts booklet.indd 1 8/2/2016 1:25:02 PM Michigan Society of Thoracic & Cardiovascular SurgeonS presidential history 1965 .......................................................................................................................................... Cameron Haight, MD 1966........................................................................................................................................... Cameron Haight, MD 1967........................................................................................................................................... Cameron Haight, MD 1968..................................................................................................................................................Paul O’Rourke, MD 1969..................................................................................................................................................Paul O’Rourke, MD 1970...................................................................................................................................... Richard Rasmussen, MD 1971...................................................................................................................................................... Conrad Lam, MD 1972...................................................................................................................................... Richard Rasmussen, MD 1973...................................................................................................................................... Richard Rasmussen, MD 1974................................................................................................................................................. Rodman Taber, MD 1975............................................................................................................................................... Forest Dodrill, MD 1976................................................................................................................................................. Rodman Taber, MD 1977................................................................................................................................................. Rodman Taber, MD 1978................................................................................................................................................. Rodman Taber, MD 1979................................................................................................................................................. Rodman Taber, MD 1980................................................................................................................................................. Rodman Taber, MD 1981................................................................................................................................................... Jack Hertzler, MD 1982........................................................................................................................................... Robert Harrison, MD 1983........................................................................................................................................... Robert Harrison, MD 1984.................................................................................................................................................. Joseph Morris, MD 1985...................................................................................................................................................... Joseph Lewis, MD 1986...................................................................................................................................................... Joseph Lewis, MD 1987...................................................................................................................................................... Luis Tomatis, MD 1988...................................................................................................................................................... Luis Tomatis, MD 1989.........................................................................................................................................................Otto Gago, MD 1990.................................................................................................................................Allen Silbergleit, MD, PhD 1991.................................................................................................................................................... Marvin Kirsh, MD 1992...................................................................................................................................................... Moufi Mitri, MD 1993......................................................................................................................................... Robert Porter, Jr., MD 1994............................................................................................................................................... Agustin Arbulu, MD 1995...................................................................................................................................................... Joseph Lewis, MD 1996........................................................................................................................................... Lawrence Patzelt, MD 1997..............................................................................................................................................Richard Prager, MD 1998...................................................................................................................................Shahrokh Mansoori, MD 1999...................................................................................................................................Shahrokh Mansoori, MD 2000.................................................................................................................................................. Daniel Drake, MD 2001................................................................................................................................................... Daniel Drake, MD 2002................................................................................................................................................... Ingida Asfaw, MD 2003................................................................................................................................................... Ingida Asfaw, MD 2004................................................................................................................................................. Joseph Bassett, MD 2005................................................................................................................................................. Joseph Bassett, MD 2006....................................................................................................................................... Frederick Armenti, MD 2007....................................................................................................................................... Frederick Armenti, MD 2008............................................................................................................................................J. Charles Heiser, MD 2009............................................................................................................................................J. Charles Heiser, MD 2010..................................................................................................................................................... Eric Hanson, MD 2011...................................................................................................................................................... Eric Hanson, MD 2012................................................................................................................................................... Timothy Sell, MD 2013.....................................................................................................................................................Timothy Sell, MD 2014...............................................................................................................................................C. Douglas Lees, MD 2015...............................................................................................................................................C. Douglas Lees, MD 2016............................................................................................................................................... Alonso Collar, MD mscvts booklet.indd 2 2 8/2/2016 1:25:02 PM Michigan Society of Thoracic & Cardiovascular SurgeonS 2014-2016 MSTCVS Board of Directors Alonso Collar, MD President 2015-2018 Robert N. Jones, MD President Elect 2015-2018 Shahrokh Mansoori, MD Secretary-Treasurer 2014-2016 C. Doulgas Lees, MD Immediate Past President 2015-2018 Reza Dabir, MD Councilor 2014-2017 Daniel Drake, MD Councilor 2013-2016 Steve Harrington, MD Councilor 2013-2016 Charles Schwartz, MD Councilor 2014-2017 Gaetano Paone, MD Councilor 2014-2017 Robert Welsh, MD Councilor 2013-2016 Frederick R. Armenti, MD MSMS Committee on Health Care Quality, Efficiency & Economics Representative Richard L. Prager, MD Peer Review & Quality Initiative Committee Chair Allen Silbergleit, MD, PhD Historian & MSMS Delegate Cindy Wikstrom Executive Director mscvts booklet.indd 3 3 8/2/2016 1:25:02 PM Letter from the President Dear Colleagues, It is my privilege to welcome all of you to a “Pure Michigan” mid-summer meeting. This is our society’s 51st meeting. The Michigan Society of Thoracic and Cardiovascular Surgeons, our Quality Collaborative Committee, and the Michigan Perfusion Society are all gathered, to once again promote “excellence” which has been our longstanding tradition. This year our president’s banquet will be held on Friday evening, a time when most of us will be able to attend. This promises to be a fun evening of food, drink, and entertainment geared to all ages! A special appearance by a comic illusionist brings us Las Vegas style entertainment. This will be followed by Tunes by T, DJ entertainment, for your dancing pleasure! Bring your families and share some fun. Friday, August 12 starts promptly at 6:00. This year’s scientific program will feature a mini-aortic symposium, a critical care update, and controversial topics in thoracic surgery. This will of course be coupled with actionable performance data from our Quality collaborative committee and the Perform dataset. Our meetings always offer generous CME’s with superb speakers in a relaxed atmosphere. I again welcome you to share some pleasant, memorable, and worthwhile days with your colleagues over the weekend. Fraternally yours, Alonso Collar M.D. President Michigan Society of Thoracic and Cardiovascular Surgeons 4 mscvts booklet.indd 4 8/2/2016 1:25:03 PM MSTCVS 2016 ON-SITE BROCHURE Table of Contents PRESIDENTIAL HISTORY.............................................................................. 2 BOARD OF DIRECTORS................................................................................. 3 LETTER FROM THE PRESIDENT..................................................................4 BRIEF HISTORY OF MSTCVS..................................................................8 & 9 SIR MAGDI YACOUB LECTURE................................................................... 10 RODMAN TABER LECTURE......................................................................... 10 SUMMER MEETING AGENDA.................................................................. 11-14 EXHIBITORS LIST...........................................................................................15 EXHIBITORS DIAGRAM................................................................................15 SPEAKERS................................................................................................... 18-22 RESIDENTS.................................................................................................23-27 NOTES......................................................................................................16 & 17 MAP OF FACILITY .........................................................INSIDE BACK PAGE 5 mscvts booklet.indd 5 8/2/2016 1:25:03 PM DISCLOSURE STATEMENTS SPEAKERS: Joseph Bavaria, MD, has no relevant financial relationships. Michael Deeb, MD, has no relevant financial relationships. Felix Fernandez, MD, has no relevant financial relationships. Richard Groom, CCP, has no relevant financial relationships. Colleen Gruenwald, RN, PhD, has a relevant financial relationship as a consultant with Medtronic Corp. Benjamin Kozower, MD, has no relevant financial relationships. Donald Likosky, PhD, has a relevant financial relationship as a principal investigator with grant/research support from Dartmouth College and AHRQ. Michael Moront, MD, has a relevant financial relationship as a consultant with Medtronic Corp,. and is on Medtronic’s speaker’s bureau and is a principal investigator with grant/research support. Mark Orringer, MD, has no relevant financial relationships. Richard Prager, MD, has no relevant financial relationships. Rishindra Reddy, MD, has a relevant financial relationship with Intuitive as he is on the speaker’s bureau at Intuitive. Alan Speir, MD, has a relevant financial relationship as a consultant on the cardiac surgery advisory board with Medtronic Corp. Glenn Whitman MD, has no relevant financial relationships. Richard Whyte, MD, has no relevant financial relationships. PLANNERS: listed Below have no relevant financial relationships. Gail Bell, RN Alonso Collar, MD Richard L. Prager, MD Patty Theurer, RN Cindy Wikstrom Jaelene Williams, RN 6 mscvts booklet.indd 6 8/2/2016 1:25:03 PM HISTORY & LEADERSHIP mscvts booklet.indd 7 8/2/2016 1:25:05 PM A Brief History of the MSTCVS By: Allen Silbergleit, M.D., Ph.D., F.A.C.S. MSMS Delegate/Historian From its inception, the mission of the Society has been to promote the highest standards of practice among the relatively small number of certified thoracic surgeons in the state. An important adjunct of the primary mission was to bring together all of the certified thoracic surgeons on a statewide basis to form a cohesive group and single voice to face the rapidly changing socio-economic issues of the times. The Michigan Society of Thoracic and Cardiovascular Surgeons (MSTCVS) began life as the Michigan Society of Thoracic Surgeons (MSTS) in 1965, an era that saw the establishment of many national, regional and state specialty societies. General medical associations, the American Medical Association and many state and county societies had been in existence since the nineteenth century and from the begining of the era of specialty societies, there had frequently been a relationship to the older general medical groups. Indeed, the first meeting of the MSTS in Detroit on September 21, 1965 was held in conjunction with and on the occasion of the centennial meeting of the Michigan State Medical Society (MSMS). The meeting was attended by 17 of the 60 board certified thoracic surgeons in Michigan at the time. The Constitution and Bylaws of the Society were written by Dr. Raymond Barrett, the first Secretary-Treasurer, and accepted by the membership. Dr. Cameron Haight was the first President. The original intent of the MSTS was to hold an annual meeting in association with the annual meeting of the MSMS and this was the case for the first 14 years. In the meantime, the Michigan Chapter of the American College of Surgeons (MCACS) attracted the attention of several state surgical specialty societies who considered it appropriate to meet in conjunction with the annual meeting of the umbrella surgical group in the state. This arrangement functioned from 1979 until 1986, when the first meeting of the MSTS took place without an affiliated group. A decision was made at that time to hold every annual meeting in the summer and generally in northern Michigan, away from the hustle and bustle of the major population areas in southern Michigan and the problem of members being called away from the meeting by their offices. From the beginning, the annual meeting featured outstanding guest speakers including some of the most prominent thoracic surgeons in the nation and the world. In 1970, an added feature to the scientific program was the presentations by MSTS members and this has utilized variably in various formats. Another feature was added in 1991, when a keynote speaker for the meeting was designated to honor a member of the Society distinguished in the specialty and in service to the Society. This lecture is generally given as a concluding event of the program. A resident competition was added to the program in 1992, providing a format for residents in thoracic surgery, general surgery, peripheral vascular surgery and pediatric surgery to compete for awards. 8 mscvts booklet.indd 8 8/2/2016 1:25:05 PM The competition was in abeyance for several years but then resumed as a highly important feature of the Society’s annual program. In recent years, there has usually been an interesting and entertaining speaker, usually a surgeon of national renown, selected as the “Luncheon Speaker.” As cardiovascular surgery had for a few decades assumed an increasingly prominent role in thoracic surgery, the council and membership considered it appropriate to reflect this in the name of the organization, although the new name would be slightly longer and more cumbersome. The Bylaws were revised in 1988 changing the name of the organization from the MSTS to the MSTCVS. The Society, with well over 100 members currently, was incorporated as a non-profit corporation in 1992. This necessitated another revision of the Bylaws, approved by the membership at the annual meeting held on August 8, 1992 on Drummond Island. A major recent endeavor of the Society is the Quality Assurance initiative that has taken solid form. This historic move reflects the commitment to quality that this Society has made to our patients and the State of Michigan. The intent of the program is to see that nothing less than the very best care possible in the sphere of thoracic and cardiovascular surgery is provided to every person in Michigan. The summer sessions held in northern Michigan are programs of national quality, and have added considerably to the annual meetings, which have become family affairs with spouses and children present, enjoying northern Michigan in the summer and attending an evening family dinner. Members of the Society get to know one another and their families during this congenial get-together. The mission of the Society is fulfilled while providing a substantial number of category 1 CME credits for a first-rate program in a casual and comfortable setting. “From the beginning, the annual meeting featured outstanding guest speakers including some of the most prominent thoracic surgeons in the nation and the world.” -Allen Silbergleit, M.D., Ph.D., F.A.C.S. 9 mscvts booklet.indd 9 8/2/2016 1:25:05 PM Michigan Society of Thoracic & Cardiovascular Surgeons presents the Sir Magdi Yacoub Lecture & Rodman Taber Lecture The Sir Magdi Yacoub lecture is awarded to a distinguished speaker who has been responsible for major innovations in our specialty. The lecture is named in honor of Sir Magdi Yacoub who is a lifetime member of MSTCVS. Sir Magdi Yacoub has received many honors including appointment to the Order of Merit by H.M. Queen Elizabeth II. Last year it was presented by Michael Mack, MD, Plano, TX. 2016 Sir Magdi Yacoub Lecture Future of Cardiothoracic and Vascular Surgery Friday the 12th at 11:15am to 12:00pm Joseph Bavaria, MD, Philadelphia, PA The Rodman Taber lecture is named in honor of our past-president and long standing Board member, Rodman Taber, MD This lectureship is awarded to a distinguished speaker who has made major contributions to Cardiothoracic Surgery. Last year it was presented by Randolph Chitwood, MD, Greenville, NC. 2016 Rodman Taber Lecture Contemporary Ethical Issues in Cardiothoracic Surgery Saturday the 13th at 11:00am to 11:45am Richard Whyte, MD, Boston, MA 10 mscvts booklet.indd 10 8/2/2016 1:25:05 PM Michigan Society of Thoracic and Cardiovascular Surgeons Summer Meeting Agenda: August 11-14, 2016 THURSDAY, AUGUST 11th 9:00am - 9:55am Data Manager Registration Mountain Grand Lodge Lobby 9:00am - 9:55am Data Manager Continental Breakfast Vienna B 10:00am - 4:00pm MSTCVS Quality Collaborative Cardiac Data Manager Meeting Vienna A 10:00am - 4:00pm MSTCVS Quality Collaborative General Thoracic Data Manager Meeting Graz A 12:00pm - 1:00pm Lunch: Data Managers Vienna B 12:00pm - 8:00pm MSTCVS Registration Civic Center West Lobby Reminder - sign in daily at the MSTCVS Registration Desk 4:30pm - 6:30pm MSTCVS Quality Committee Meeting Vienna B (Committee Member Surgeons Only) Richard Prager, MD, Ann Arbor, MI 6:00pm -7:00pm Welcome Reception – All Meeting Attendees Vienna Patio 7:00pm - 10:00pm MSTCVS Quality Collaborative Meeting Matterhorn CD Moderator: Richard Prager, MD, Ann Arbor, MI 7:00pm – 7:30pm 7:30pm – 8:00pm 8:00pm – 8:30pm 8:30pm – 9:00pm 9:00pm – 10:00pm MSTCVS Updates Ten Years of POCMA Patient Reported Outcomes Felix Fernandez, MD, Atlanta, GA MSTCVS Site Visit Report TAVR POCMA 11 mscvts booklet.indd 11 8/2/2016 1:25:05 PM Michigan Society of Thoracic and Cardiovascular Surgeons Summer Meeting Agenda: August 11-14, 2016 FRIDAY, AUGUST 12th 6:30am - 4:00pm MSTCVS Registration Civic Center West Lobby Reminder - sign in daily at the MSTCVS Registration Desk 6:30am - 7:55am Breakfast with Exhibitors Matterhorn AB 8:05am - 8:10am Welcome Matterhorn CD Alonso Collar, MD, MSTCVS President, Lansing, MI Mini Aortic Symposium Matterhorn CD 8:10am - 8:40am Current Therapy for Type A and B Aortic Dissection Joseph Bavaria, MD, Philadelphia, PA 8:40am - 9:10am TAVR in 2016 Michael Deeb, MD, Ann Arbor, MI 9:10am - 9:40am Minimally Invasive Aortic Valve Surgery Michael Moront, MD, Toledo, OH 9:40am - 10:00am Panel Discussion 10:00am - 10:30am Break with Exhibitors Matterhorn AB Please take a moment to visit each exhibitor and thank them for their support 10:30am - 11:15am Public Reporting of Surgical Outcomes Matterhorn CD Benjamin Kozower, MD, MPH, St. Louis, MO 11:15am - 12:00pm 2016 Sir Magdi Yacoub Lecture Matterhorn CD Future of Cardiothoracic and Vascular Surgery Joseph Bavaria, MD, Philadelphia, PA 12:00pm - 1:15pm Lunch Matterhorn CD Alternate Payment Models Alan Speir, MD, Falls Church, VA 1:15pm - 4:00pm MSTCVS Quality Collaborative Meeting Matterhorn CD Moderator: Richard Prager, MD, Ann Arbor, MI 1:15pm – 2:30pm 2:30pm – 3:00pm 3:00pm – 4:00pm 4:00pm - 6:00pm 6:00pm - 10:00pm General Thoracic Data Review STS General Thoracic Workforce Database Update Benjamin Kozower, MD, MPH, St. Louis, MO Cardiac Surgical AVR/TAVR and Aortic Procedure Data Review Free Time for Family Activities MSTCVS Annual Banquet & Entertainment Vienna ENTERTAINMENT: PiP the COMIC ILLUSIONIST see next page for all the details on this amazing entertainer!!! 12 mscvts booklet.indd 12 8/2/2016 1:25:08 PM FRIDAY NIGHT FROM 6-10 PM is the MSTCVS ANNUAL BANQUET FEATURING PiP the COMIC ILLUSIONIST In 2014 PiP Comic Illusionist, was a finalist on Australia’s Got Talent 2012. Classified as an ‘ALIEN WITH EXTRAORDINARY ABILITY’ he is a must see act!! Now based in Las Vegas Nevada he showcases his critically acclaimed sell out shows are pushing the art form of magic, thanks to the unique and eccentric style of illusions he creates. His tours have included sold out shows during the Adelaide Fringe, Sydney Comedy Festival, Melbourne International Comedy Festival, Melbourne Magic Festival & at major venues including the iconic Sydney Opera House. More recently he has been seen in Las Vegas at the Hard Rock Hotel & Casino, The Cosmopolitan, The Downtown Grand Hotel & Casino & Playboy parties at The Palms. Please note that 1 ticket is included with your registration. To purchase additional tickets, please see the MSTCVS Registration Desk. 13 mscvts booklet.indd 13 8/2/2016 1:25:08 PM Michigan Society of Thoracic and Cardiovascular Surgeons Summer Meeting Agenda: August 11-14, 2016 SATURDAY, AUGUST 13th 6:45am - 4:00pm MSTCVS Registration Civic Center West Lobby Reminder - sign in daily at the MSTCVS Registration Desk 7:00am- 7:55am Pneumonia Prevention Meeting Aurora Donald Likosky, PhD, Ann Arbor, MI 6:30am - 7:55am Breakfast with Exhibitors Matterhorn AB 8:05am - 8:15am Welcome Matterhorn CD Alonso Collar, MD, MSTCVS President, Lansing, Ml 8:15am - 9:00am Critical Care Management of Cardiovascular Patients Matterhorn CD Glenn Whitman, MD, Baltimore, MD 9:00am - 9:30am Quality Measurement and Quality Improvement in Lung Cancer Surgery Matterhorn CD Felix Fernandez, MD, MSC, Atlanta, GA 9:30am - 10:00am Robotic Lobectomy: Technical Tips and Pitfalls Matterhorn CD Rishindra Reddy, MD, Ann Arbor, MI 10:00am - 10:30am Break with Exhibitors Matterhorn AB Please take a moment to visit each exhibitor and thank them for their support 10:30am - 11:00am GERD and Hiatal Hernias: Old Principles Still Matter Matterhorn CD Mark Orringer, MD, Ann Arbor, MI 11:00am - 11:45am 2016 Rodman Taber Lecture Matterhorn CD Contemporary Ethical Issues in Cardiothoracic Surgery Richard Whyte, MD, Boston, MA 12:00pm - 1:00pm Lunch with Exhibitors Matterhorn AB 1:00pm - 1:30pm Resident Paper Session Matterhorn CD Moderator: Allen Silbergleit, MD, Pontiac, MI 1:30pm - 4:00pm MSTCVS Quality Collaborative Meeting Matterhorn CD Moderator: Richard Prager, MD, Ann Arbor, MI 1:30pm – 2:30pm 2:30pm – 3:00pm 3:00pm – 3:30pm 3:30pm – 3:45pm 3:45pm – 4:00pm 4:00pm MSTCVS CAB and Mitral Data Goal Directed Perfusion Robert Groom, CCP, MS Portland, ME Pneumonia Prevention Panel Case Presentation Meeting Wrap up and Evaluation Free Time for Family Activities SUNDAY, AUGUST 14th 7:30am - 8:30am MSTCVS Surgeon Breakfast Business Meeting with Election Results Vienna B 7:30am - 10:30am MSTCVS/ MI Perfusion Society Breakfast Meeting Vienna A mscvts booklet.indd 14 14 8/2/2016 1:25:11 PM Exhibitors List & Booth Diagram COMPANY........................................... BOOTH # Abiomed, Inc........................................................................ 1 Astute Medical, Inc............................................................ 26 Atricure, Inc........................................................................... 3 CyroLife................................................................................ 8 Edwards Lifesciences........................................................ 14 Essential Pharmaceuticals.................................................. 5 Ethicon................................................................................. 12 General Cardiac Technology........................................... 6 Gore & Associates............................................................ 21 Grifols................................................................................. 20 HeartWare, Inc.................................................................... 7 KLS Martin............................................................................ 9 LivaNova............................................................................... 4 LSI Solutions........................................................................ 19 Mallinckrodt Pharmaceuticals......................................... 10 Maquet Medical Systems................................................ 18 MassMutal Michigan Metro............................................. 11 Medtronic (Heart valves, Revascularization, Ablation, & Perfusion).............17 Medtronic (INVOS, BIS)......................................................................................... 22 Medtronic AST (Stapling, Energy, Endomechanical.....................................24 Myriad Genetics, Inc........................................................ 28 Quest Medical..................................................................... 2 RTI Surgical, Inc................................................................. 27 DePuy Synthes................................................................... 23 St. Jude Medical............................................................... 13 Terumo Cardiovascular Group....................................... 15 The Medicines Company.................................................. 16 Exhibitor Hours Friday, August 12th, 2016 from 6:30am to 4:30pm Saturday, August 13th , 2016 from 7:00am to 4:00pm Exhibit Hall: Matterhorn AB mscvts booklet.indd 15 15 8/2/2016 1:25:11 PM NOTES 16 mscvts booklet.indd 16 8/2/2016 1:25:11 PM NOTES 17 mscvts booklet.indd 17 8/2/2016 1:25:11 PM 2016 SPEAKERS mscvts booklet.indd 18 8/2/2016 1:25:12 PM Joseph Bavaria, MD Dr. Joseph Bavaria is currently the Brooke Roberts-William M. Measey Professor of Surgery and Vice-Chief, Division of Cardiovascular Surgery at the Hospital of the University of Pennsylvania. He is President-Elect of The Society of Thoracic Surgeons. He is Director of the Thoracic Aortic Surgery Program at PENN which is a multidisciplinary program encompassing all aspects of aortic disease including thoracic aortic reconstruction and Marfan’s Syndrome. His primary interests include thoracic aortic surgery and more broadly, Cardio-Aortic surgery. This includes aortic dissection, aortic root and ascending aortic reconstruction, aortic arch surgery and the circulation management necessary for successful aortic arch clinical outcomes. Additionally, Dr. Bavaria’s clinical interests include thoracoabdominal aortic aneurysm surgery and a very busy program in the field of thoracic aortic endovascular stent grafting (TEVAR). G. MICHAEL DEEB, M.D. Early on at Temple University Hospital as Asst. Professor of Surgery establishing their heart and lung transplantation program. In 1986 moved to the University of Michigan as Director of the Heart Transplant Program. He was the first surgeon to successfully perform a heart/lung transplant, single & double lung transplant and insert a total artificial heart and an implantable mechanical assist device in Michigan. 1990-became director of the Adult Cardiac Surgery Service at the U of M Medical Center. 1991-promoted to an Associate Professor. 1995-Established the aortic program at U of M. 1996-promoted to Professor, appointed the Director of the Multidisciplinary Aortic Clinic and Co-Director of the Heart Care Program at U of M. 2004-he is the first Herbert Sloan Collegiate Professor of Cardiac Surgery. 2006-The University of Pittsburgh Dept. of Chemistry Alumni Award. 2007-U of M Medical School Dean’s Award for Outstanding Clinician. 2008-Forest Dewey Dodrill Award for Excellence, Outstanding Clinician American Heart Association. 2012-Inducted by U of M into the League of Clinical Excellence. 2014-he was awarded The Mark B. Orringer Thoracic Surgery Teaching Award from U of M. 2015-Coeur D’Or Award of Excellence by the American Heart Association in Detroit, MI. Felix G. Fernandez, MD, MSc Felix G. Fernandez, MD, MSc, is an Associate Professor of Surgery at Emory University School of Medicine Wayne State University School of Medicine 2000 General surgery and cardiothoracic surgery training at Barnes Jewish Hospital completed in 2009 Clinical focus on thoracic oncology and academic focus on health services research. 19 mscvts booklet.indd 19 8/2/2016 1:25:13 PM Benjamin D. Kozower, MD, MPH Benjamin D. Kozower, MD, MPH is a Professor of Surgery in the Division of Cardiothoracic Surgery. He practiced for 10 years at the University of Virginia and joined the faculty at Washington University in St. Louis this August. Dr. Kozower completed his undergraduate and medical degrees from the University of Rochester. He completed his general surgery training at the University of Connecticut and his thoracic surgery residency at Washington University School of Medicine in St. Louis, MO. His postdoctoral studies include a thoracic surgery research fellowship at Washington University and a Master of Public Health degree from the University of Virginia. For leisure, Dr. Kozower enjoys hiking and cooking. Donald Likosky, PhD Dr. Likosky is an Associate Professor in the Department of Cardiac Surgery at the University of Michigan, where is serves as the Section Head for Health Services Research and Quality. He is also a faculty member at the Center for Healthcare Outcomes and Policy. Dr. Likosky has held leadership positions within a number of quality improvement collaboratives, including the Associate Director for the Northern New England Cardiovascular Disease Study Group, and epidemiologist for the Vascular Study Group of New England. He is the Director of the International Consortium for Evidence-Based Perfusion (ICEBP), a partnership and collaboration between perfusion societies, medical societies, clinicians and industry to improve continuously the delivery of care and outcomes for cardiac surgical patients. He is the co-founder and the Research Director for the PERFusion Measures and outcomes (PERForm) registry, a cardiovascular perfusion registry. Michael Moront, MD A native of Upstate New York, Dr. Moront graduated from Boston College Magna Cum Laude-Phi Beta Kappa with studies in biochemistry and economics and then attended Georgetown University School of Medicine where he received his Medical degree and was selected into Alpha Omega Alpha Medical Honor Society. Dr. Moront continued on at Georgetown Medical Center and completed a General Surgery Residency and a year of Research as an American Heart Association Fellow concentrating on Neonatal Exacorporeal Membrane Oxygenation. Dr. Moront received his Cardiac Surgical training, including a year of Pediatric Cardiac Surgical training, at the University of Alabama at Birmingham. Currently, Dr. Moront serves as the Director of Cardiac Surgical Research and the Surgical Director of the Structural Hearth Team for Toledo Hospital and Promedica Health System. 20 mscvts booklet.indd 20 8/2/2016 1:25:14 PM Mark B. Orringer, MD Mark B. Orringer, MD, is the Cameron Haight Distinguished University Professor of Thoracic Surgery at the University of Michigan. He was a Phi Beta Kappa graduate of the University of Pittsburgh undergraduate school in 1963 and an Alpha Omega Alpha graduate of the University of Pittsburgh Medical School in 1967. He completed his general surgery and thoracic surgery residency training at The Johns Hopkins Hospital in 1973. During his surgery residency, while at the Frenchay Hospital in Bristol, England under the mentorship of Mr. Ronald Belsey, he gained additional exposure tothe field of general thoracic surgery, particularly the surgical treatment of esophageal disease. As one of the country’s current leaders in the field of thoracic surgery, Dr. Orringer has focused much of his academic career on the diagnosis and treatment of benign and malignant esophageal disease. He has developed two leading esophageal operations: the transhiatal esophagectomy without thoracotomy and the combined Collis-Nissen hiatal hernia repair. Rishindra reddy, MD Rishindra M. Reddy, MD, was born and raised in Michigan. He earned his undergraduate and medical degrees at Northwestern University, and completed his general surgery residency at Washington University-Barnes Jewish Hospital in St.Louis, Missouri. His spent two years during his residency, as a Clinical Research Fellow at the National Cancer Institute in Bethesda, Maryland. He completed his Thoracic Surgery residency at the University of Washington and was a visiting fellow at Memorial Sloan Kettering Cancer Center in New York. Dr. Reddy’s clinical interests include all aspects of general thoracic surgery including thoracic oncology, minimally invasive techniques, pectus repair and therapy for end-stage lung disease including transplantation and lung volume reduction surgery. His academic interests include improving outcomes for patients with thoracic cancers, molecular targeting for thoracic cancers, resident and medical student education. Richard L. Prager, MD After training in General Surgery and Thoracic Surgery at the University of Michigan, Dr. Prager began his cardiac and thoracic surgical career at Vanderbilt University as an Assistant Professor in the Department of Cardiac and Thoracic Surgery returning to Ann Arbor in 1983 to join the Cardiac and Thoracic Surgical Group at St. Joseph Mercy Hospital. Dr. Prager was the Medical Director of the HCFA Demonstration Project at St. Joseph Mercy Hospital and the Head of the Section of Cardiac and Thoracic Surgery. In 1999, he moved to University of Michigan as a Professor of Surgery and Head, Section of Adult Cardiac Surgery. Dr. Prager leads the Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative Initiative and is a Director of the University of Michigan’s Frankel Cardiovascular Center. He is the President of the Society of Thoracic Surgeons and past President of the Southern Thoracic Surgical Association. In July, 2016 he stepped down as Section Head of Adult Cardiac Surgery and Associate Program Director of the Thoracic Surgery Fellowship and the Integrated Cardiac and Thoracic Surgical residency. mscvts booklet.indd 21 21 8/2/2016 1:25:14 PM Alan M. Speir, MD Alan M. Speir, MD has been a practicing cardiothoracic surgeon in the metropolitan Washington, DC area for 34 years and is currently the Medical Director of Cardiac Surgery for the Inova Health System. He has considerable expertise and interest in quality improvement and cost containment in health care and is a recognized national leader in developing alternative delivery and payment models to improve patient care and lower costs. Speir was instrumental in founding the Virginia Cardiac Surgery Quality Initiative (VCSQI) in 1993 and now serves as Chairman of this statewide quality organization, which includes 17 hospitals and 12 cardiac surgical practices performing over 99 percent of the cardiac surgery in the Commonwealth of Virginia. The primary goal of the VCSQI is to improve outcomes and reduce costs in cardiac surgery by process improvement, and to foster collaboration among all programs via data sharing, process change, and improved efficiency. Richard Whyte, MD Richard Whyte, MD, is a native of the United Kingdom but grew up in Pittsburgh, PA. Richard Whyte attended The University of Pittsburgh for his undergraduate degree and medical school. Completed his internship and residency in General Surgery at Massachusetts General Hospital (1983-1990). Thoracic surgical residency at University of Michigan (1990-1992). John Alexander Fellowship at UM in 1993, then faculty (Assistant Professor) through 1997. Stanford University from 1997- 2011 initially as Chief of Thoracic Surgery, then Vice-Chair of the Department of Cardiothoracic Surgery. Appointed as Associate Professor in 1997 and promoted to (full) Professor in 2003. Obtained MBA from Wharton School in 2006. Relocated to Boston as Vice-Chair of Surgery at Beth Israel Deaconess with appointment as Professor at Harvard Medical School in 2011. Glen Whitman, MD Dr. Whitman is the Associate Professor of Surgery and the Director of the CVSICU and Heart Transplant program at Johns Hopkins. He previously served as the Chief of Cardiac Surgery at the Medical College of Pennsylvania, as well as the University of Maryland. His current focus at Hopkins is on systems improvements and quality assurance in Cardiac Surgery Critical Care. Among all of his areas of interest,teaching is foremost. He has received the golden apple and golden scalpel awards on several occasions. 22 mscvts booklet.indd 22 8/2/2016 1:25:15 PM 2016 RESIDENTS mscvts booklet.indd 23 8/2/2016 1:25:15 PM Non-thrombogenic Coating in Extracorporeal Circulation Using Nitric Oxide Releasing Materials BY AZMATH MOHAMMED, MD INTRODUCTION: Cardiopulmonary Bypass (CPB) and Extracorporeal Membrane Oxygenation (ECMO) are two types of lifesaving procedures that involve extracorporeal circulation (ECC) of flow of blood through devices. One challenging aspect of ECC is requirement of systemic anticoagulation with its associated high risk of major bleeding (3-36%). In order to circumvent systemic heparinization, non-thrombogenic surfaces coated with heparin or hydrophilic molecules bound to inner surface have been developed without major success as systemic heparinization is still required. Nitric oxide (NO) is a known potent inhibitor of platelet activation and adhesion and it is released from healthy endothelial cells. We investigate embedding argatroban and NO releasing materials (S-nitroso-N-acetylpenicillamine, SNAP and diazeniumdiolate dibutyl hexanediamine, DBHD) into a CarboSil® polymer which creates a smooth coating inside ECC devices therefore minimizing thrombosis. METHODS: Twenty-four New Zealand white rabbits were used for our studies. Following induction of anesthesia, tracheostomy and placement of hemodynamic monitoring lines, an arteriovenous shunt was created by cannulating the left carotid artery and right external jugular vein. This circuit was made of 3/8” ID Tygon® poly(vinyl chloride) tubing. Six groups were studied: (1) control circuits (n=4) without coating, (2) SNAP in CarboSil® polymer circuits (n=4) with the addition of white light-emitting diodes (L.E.D.), (3) SNAP in CarboSil® polymer circuits (n=4) with copper, (4) DBHD in CarboSil® polymer circuits (n=4), (5) DBHD in Ca rboSil® polymer circuits (n=4) with argatroban coating, (6) systemic heparin with no coating (n=4). Coated ECC circuits were tested for 4hr in rabbits without systemic anticoagulation. Systemic hemodynamics, ECC blood flow, and blood samples were collected at baseline, and hourly intervals. End-point parameters included thrombus area, plasma fibrinogen levels, platelet count, and platelet function tests via aggregometry. At the end of the study, ECC circuits were clamped, removed from animals, and gently rinsed with 60 mL of normal saline (0.9%). Residual thrombus was photographed and quantitated. Comparison between groups was analyzed by a comparison of means using student’s t-test. RESULTS: Figure 1 illustrates circuit thrombus area for each group. Circuits coated with DBHD/argatroban had the least thrombus area while control group was fully clotted. Initial circuit blood flow rates in all groups were between 54-80mL/min. Platelet counts were preserved in SNAP and DBHD circuits while control circuit showed significant decline (Figure 2). Platelet function tests using aggregometry showed significant decline in platelet function in control circuits compared to SNAP and DBHD circuits (Figure 3). CONCLUSION: This study demonstrates that circuits coated with nitric oxide releasing materials (SNAP and DBHD) in a 4 hour rabbit model of extracorporeal circulation has decreased thrombus formation without the use of systemic anticoagulation. Attempts to maximize NO release from the coatings by increasing L.E.D. intensity and copper did not yield clot reduction. Additionally, circuits were coated with a second layer of direct thrombin inhibitor (argatroban)attenuated clot formation by inhibiting the coagulation cascade. Long term rabbit and sheep models are currently being tested to assess efficacy of our combined non-thrombogenic surface coatings. SEE FIGURES ON NEXT PAGE 24 mscvts booklet.indd 24 8/2/2016 1:25:15 PM Figure 1: Circuit Thrombus Area Figure 2: Platelet Counts During 4hr Circuit Time Figure 3: Platelet Aggregation % During 4hr Circuit Time mscvts booklet.indd 25 25 8/2/2016 1:25:16 PM Efficacy of Transcutaneous Cerebral Oximetry Monitoring During Carotid Endarterectomy BY Jeorge WEBER, MD OBJECTIVES: Disease of the internal carotid artery is estimated to account for 15-20% of ischemic strokes. No standard exists for intraoperative monitoring of cerebral perfusion during carotid endarterectomy (CEA). The purpose of this pilot study was to monitor the adequacy of cerebral oxygenation as a result of cerebral blood flow using the NONIN Sensmart Cerebral Oximeter in patients undergoing CEA and analyze trends in data that could alert to earlier signs of inadequate perfusion. METHODS: Patients were selected based on current recommendations for CEA. 51 consecutive patients undergoing CEA were monitored using a NONIN Sensmart Oximetry device. Data was recorded at defined intervals. Repeated measures ANOVA was performed to assess potential differences in oximetry on the ipsilateral side as the procedure at baseline, clamping of carotid artery, shunt placement, and extubation. PROC GLM in SAS 9.4 was used to perform all analyses, and a significance level of α = 0.05 was used for significance. Patients deemed to have had “intraoperative cerebral events” were further analyzed. RESULTS: 51 patients were included in the analysis. The average baseline value on the ipsilateral side was 69.1%. After shunt placement, the value increased by an average of 3.38 units (95% CI 1.19-5.58, P= <0.0001). The average oximetry value at the time of carotid clamping was 2.3 units higher than at the time of shunt placement (95% CI 0.11-4.5, P= 0.0401). When comparing extubation values to those at baseline, there was an average of a 10.78 unit increase in value (95% CI 8.60-12.96, P= <0.0001). No difference existed comparing baseline values with those at the time of clamping (P=0.314). Two patients were selected out based on observed adverse clinical outcome. The first patient had oximetry values lower than expected after flow was restored had CT evidence of ischemia. The second patient suffered profound hypotension intraoperatively as a consequence of Protamine administration. CONCLUSIONS: Patients who undergo carotid endarterectomy are at risk for developing intra-operative complications related to inadequate cerebral flow. Though no standard exists and surgeon preference dictates practice, the NONIN Sensmart Oximeter has shown promise as an adjunct and tool that could alert the surgeon to early signs of inadequate perfusion. 26 mscvts booklet.indd 26 8/2/2016 1:25:16 PM Thoracic EndoVascular Aortic Repair for Symptomatic and Ruptured Aneurysms and Penetrating Ulcers BY Peter BEAULIEU, MD BACKGROUND: In large multicenter studies, the clinical outcomes of Thoracic EndoVascular Aortic Repair (TEVAR) for traumatic tears are superior to open repair. TEVAR can also be considered for a variety of other acute pathologies of the thoracic aorta. HYPOTHESIS: TEVAR for ruptured thoracic aortic aneurysms, intramural hematoma or penetrating ulcers is safe with good intermediate survival. DESIGN: Retrospective review of our TEVAR database. SETTING: Large urban tertiary referral medical center. PATIENTS AND METHODS: The clinical presentation and diagnostic studies of patients presenting for urgent or emergent TEVAR were reviewed. Operative details, complications, short and long-term outcomes were reviewed. We excluded all patients undergoing emergent TEVAR for traumatic tears. RESULTS: In a 8-year period ending in May 2015, we found 28 patients subjected to urgent/emergent TEVAR; group A included 16 (9 females) for penetrating ulcers or intramural hematoma and group B had 12 (5 females) for ruptured throacic aneurysms. Iliac or aortic conduits were constructed to deliver the endograft in 3 patients in group A and 4 in group B. One patient in each group required a snorkel to protect an important side branch (celiac, left carotid). There were no acute myocardial infarctions or postoperative paraplegias. Average follow-up was 3 years. One patient in each group died. One patient in group B returned 3 years later with a type I endoleak and was reoperated. Overall, there were no significant differences between groups and excellent mid-term survival and freedom from re-intervention were achieved. CONCLUSION: Emergent TEVAR for ruptured thoracic aneurysms, penetrating ulcers and intramural hematomas is safe with reasonable short and intermediate term outcomes in selected patients. 27 mscvts booklet.indd 27 8/2/2016 1:25:16 PM MSTCVS would like to extend a warm thank you to all our amazing exhibitors At HeartWare, we are focused on innovation and enhancing outcomes in the treatment of end stage heart failure. With the rising utilization of the HVAD® System in the market, it has quickly become the VAD of choice, demonstrating high survival rates, low complication rates and improved quality of life. mscvts booklet.indd 28 8/2/2016 1:25:16 PM MSTCVS would like to extend a warm thank you to all our amazing exhibitors Innovation. It’s at the heart of what we do. Hoopless End Effector Small Diameter End Effector (12 mm) Active Articulation Levers A Simplified Approach to LAA Exclusion AtriClip PRO2™ Device Enhanced Flexibility Uniform Lesion Engineered for Performance Flexibility Desired, Consistency Needed Probe See what we do at our MSTCVS Booth Rx Only Indications: cryoFORM: The cryoICE® cryoablation probes are indicated for use in the cryosurgical treatment of cardiac arrhythmias. AtriClip PRO2: The AtriClip® Left Atrial Appendage (LAA) Exclusion System is indicated for the occlusion of the LAA, under direct visualization, in conjunction with other open cardiac surgical procedures. MKT-2038B-G mscvts booklet.indd 29 www.atricure.com 8/2/2016 1:25:18 PM MSTCVS would like to extend a warm thank you to all our amazing exhibitors mscvts booklet.indd 30 8/2/2016 1:25:19 PM MSTCVS would like to extend a warm thank you to all our amazing exhibitors mscvts booklet.indd 31 8/2/2016 1:25:21 PM MSTCVS would like to extend a warm thank you to all our amazing exhibitors Jeff Morgan St. Jude Medical A SPECIAL THANK YOU TO OUR GOLD SPONSORS mscvts booklet.indd 32 8/2/2016 1:25:22 PM MSTCVS would like to extend a warm thank you to all our amazing exhibitors mscvts booklet.indd 33 8/2/2016 1:25:23 PM MSTCVS would like to extend a warm thank you to all our amazing exhibitors mscvts booklet.indd 34 8/2/2016 1:25:23 PM mscvts booklet.indd 35 8/2/2016 1:25:24 PM Save Save the the Date Date 2017 2017 MSTCVS MSTCVS Annual Annual Summer Summer Meeting Meeting July July 27th-July 27th-July 30th, 30th, 2017 2017 at at The The Grand Grand Traverse Traverse Resort Resort le a r n MORE AT w w w. M S TC V S.OR G T he Michig a n S o ciet y of T hor a cic & C ardio va s cul a r Surgeo ns mscvts booklet.indd 36 8/2/2016 1:25:25 PM